Disclosed are as represented by Formula (I) a quinazoline derivative and a pharmaceutical acceptable salt thereof, or, an enantiomer, a non-enantiomer, a tautomer, a racemate, a solvate, a metabolic precursor, or a prodrug of both. Also disclosed are a preparation method therefor, an intermediate, a pharmaceutical composition having the quinazoline derivative, and an application thereof. The quinazoline derivative of the present invention is provided with improved anti-tumor activity.
根据公式(I)所表示的是
喹唑啉衍
生物及其药用可接受盐,或者其对映体、非对映体、互变异构体、消旋体、溶剂合物、代谢前体或两者的前药。还公开了其制备方法、中间体、含有
喹唑啉衍
生物的药物组合物以及其应用。本发明的
喹唑啉衍
生物具有改善的抗肿瘤活性。